Evaluation of quantitative miRNA expression platforms in the microRNA quality control (miRQC) study P Mestdagh, N Hartmann, L Baeriswyl, D Andreasen, N Bernard, C Chen, ... Nature methods 11 (8), 809-815, 2014 | 665 | 2014 |
Integrative annotation of 21,037 human genes validated by full-length cDNA clones T Imanishi, T Itoh, Y Suzuki, C O'donovan, S Fukuchi, KO Koyanagi, ... PLoS biology 2 (6), e162, 2004 | 427 | 2004 |
Mammalian overlapping genes: the comparative perspective V Veeramachaneni, W Makalowski, M Galdzicki, R Sood, I Makalowska Genome research 14 (2), 280-286, 2004 | 175 | 2004 |
An international effort towards developing standards for best practices in analysis, interpretation and reporting of clinical genome sequencing results in the CLARITY Challenge CA Brownstein, AH Beggs, N Homer, B Merriman, TW Yu, KC Flannery, ... Genome biology 15, 1-18, 2014 | 121 | 2014 |
Next-generation sequencing of human mitochondrial reference genomes uncovers high heteroplasmy frequency MX Sosa, IKA Sivakumar, S Maragh, V Veeramachaneni, R Hariharan, ... PLoS computational biology 8 (10), e1002737, 2012 | 88 | 2012 |
Screening of over 1000 Indian patients with breast and/or ovarian cancer with a multi-gene panel: prevalence of BRCA1/2 and non-BRCA mutations J Singh, N Thota, S Singh, S Padhi, P Mohan, S Deshwal, S Sur, M Ghosh, ... Breast cancer research and treatment 170, 189-196, 2018 | 85 | 2018 |
Detection of high frequency of mutations in a breast and/or ovarian cancer cohort: implications of embracing a multi-gene panel in molecular diagnosis in India AU Mannan, J Singh, R Lakshmikeshava, N Thota, S Singh, TS Sowmya, ... Journal of human genetics 61 (6), 515-522, 2016 | 77 | 2016 |
Eighty percent of proteins are different between humans and chimpanzees G Glazko, V Veeramachaneni, M Nei, W Makałowski Gene 346, 215-219, 2005 | 70 | 2005 |
Mastering seeds for genomic size nucleotide BLAST searches V Gotea, V Veeramachaneni, W Makałowski Nucleic acids research 31 (23), 6935-6941, 2003 | 35 | 2003 |
Multi-gene testing in neurological disorders showed an improved diagnostic yield: data from over 1000 Indian patients A Ganapathy, A Mishra, MR Soni, P Kumar, M Sadagopan, AV Kanthi, ... Journal of Neurology 266, 1919-1926, 2019 | 31 | 2019 |
Ultrasensitive detection of tumor‐specific mutations in saliva of patients with oral cavity squamous cell carcinoma A Shanmugam, AK Hariharan, R Hasina, JR Nair, S Katragadda, ... Cancer 127 (10), 1576-1589, 2021 | 30 | 2021 |
Next-generation sequencing-based method shows increased mutation detection sensitivity in an Indian retinoblastoma cohort J Singh, A Mishra, AJ Pandian, AC Mallipatna, V Khetan, S Sripriya, ... Molecular vision 22, 1036, 2016 | 23 | 2016 |
Analysis of solid tumor mutation profiles in liquid biopsy SA Balaji, A Shanmugam, A Chougule, S Sridharan, K Prabhash, A Arya, ... Cancer medicine 7 (11), 5439-5447, 2018 | 22 | 2018 |
Aligning two fragmented sequences V Veeramachaneni, P Berman, W Miller Discrete Applied Mathematics 127 (1), 119-143, 2003 | 12 | 2003 |
Validation of whole genome sequencing from dried blood spots P Agrawal, S Katragadda, AK Hariharan, VG Raghavendrachar, ... BMC Medical Genomics 14, 1-11, 2021 | 11 | 2021 |
Visualizing sequence similarity of protein families V Veeramachaneni, W Makałowski Genome research 14 (6), 1160-1169, 2004 | 11 | 2004 |
StrandAdvantage test for early‐line and advanced‐stage treatment decisions in solid tumors M Sen, S Katragadda, A Ravichandran, G Deshpande, M Parulekar, ... Cancer Medicine 6 (5), 883-901, 2017 | 6 | 2017 |
Release of (and lessons learned from mining) a pioneering large toxicogenomics database KS Sandhu, V Veeramachaneni, X Yao, A Nie, P Lord, D Amaratunga, ... Pharmacogenomics 16 (8), 779-801, 2015 | 6 | 2015 |
DED: database of evolutionary distances V Veeramachaneni, W Makałowski Nucleic acids research 33 (suppl_1), D442-D446, 2005 | 6 | 2005 |
Detection of somatic mutations in saliva of patients with oral cavity squamous cell carcinoma. E Izumchenko, R Hasina, AK Hariharan, A Shanmugam, S Irusappan, ... Journal of Clinical Oncology 38 (15_suppl), 6562-6562, 2020 | 5 | 2020 |